Biobanking Market Size-By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Biobanking Market Size-By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032


Global Biobanking Market Overview

According to SPER Market Research, the Global Biobanking Market is estimated to reach USD 112.18 billion by 2032 with a CAGR of 4.84%. Gathering and conserving biological samples for use in research, biodiversity studies, and diagnostics are all parts of the biobanking process. Biobanks are necessary to assist biomedical research projects, offer individualised care, and maintain age demographic records. Technology-advanced market structures called biobanking markets are occupied with gathering and preserving biological data, materials, and samples for use in the future, as well as with learning more about various disorders, examining the effects of various diseases, and also with discovering a cure for them.

Impact of COVID-19 on the Global Biobanking Market

The novel coronavirus, also known as Covid 19, has had a negative effect on the biobanking industry because of the risks involved with the storage, collection, and processing of human biospecimens and all biological materials due to the increased risk of virus and other infection transmission during this pandemic period. The ramifications of the SARS CoV-2 infection and subsequent transmission of the lethal virus have become a threat to the majority of biobanking companies.

Scope of the Report:

Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032

Segments covered By Specimen Type, By Type of Biobank, By Ownership, By Application, By End User.

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered BioIVT & Elevating Science, Geneticist Inc, Firalis S.A., AMS biotechnology Ltd. (AMSBIO LLC), and US Biolab Corporation, Inc., ProteoGenex, Inc., Cureline, Inc.

By Specimen Type: Based on the Specimen Type, Global Biobanking Market is segmented as; Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, and Others.

By Type of Biobank: Based on the Type of Biobank, Global Biobanking Market is segmented as; Population-based Biobanks, and Disease-oriented Biobanks.

By Application: Based on the Application, Global Biobanking Market is segmented as; Therapeutics, Research.

By End User: Based on the End User, Global Biobanking Market is segmented as; Academic Institutes, Pharma & Biotech Companies.


1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Biobanking Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Biobanking Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biobanking Market
7. Global Biobanking Market, By Specimen Type, 2019-2032 (USD Million)
7.1 Blood Products
7.2 Solid Tissue
7.3 Cell Lines
7.4 Nucleic Acid
7.5 Others
8. Global Biobanking Market, By Type of Biobank, 2019-2032 (USD Million)
8.1 Population-based Biobanks
8.2 Disease-oriented Biobanks
9. Global Biobanking Market, By Ownership, 2019-2032 (USD Million)
9.1 National/regional agency
9.2 Non-profit Organization
9.3 Universities
9.4 Private Organization
10. Global Biobanking Market, By Application, 2019-2032 (USD Million)
10.1 Therapeutics
10.2 Research
11. Global Biobanking Market, By End User, 2019-2032 (USD Million)
11.1 Academic Institutes
11.2 Pharma & Biotech Companies
12. Global Biobanking Market, By Region, 2019-2032 (USD Million)
12.1 Global Biobanking Market Size and Market Share by Region (2019-2025)
12.2 Global Biobanking Market Size and Market Share by Region (2026-2032)
12.3 Asia-Pacific
12.3.1 Australia
12.3.2 China
12.3.3 India
12.3.4 Japan
12.3.5 South Korea
12.3.6 Rest of Asia-Pacific
12.4 Europe
12.4.1 France
12.4.2 Germany
12.4.3 Italy
12.4.4 Spain
12.4.5 United Kingdom
12.4.6 Rest of Europe
12.5 Middle East and Africa
12.5.1 Kingdom of Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Rest of Middle East & Africa
12.6 North America
12.6.1 Canada
12.6.2 Mexico
12.6.3 United States
12.7 Latin America
12.7.1 Argentina
12.7.2 Brazil
12.7.3 Rest of Latin America
13.Company Profiles
13.1 AMS biotechnology Ltd (AMSBIO LLC)
13.1.1 Company details
13.1.2 Financial outlook
13.1.3 Product summary
13.1.4 Recent developments
13.2 Bay Biosciences LLC
13.2.1 Company details
13.2.2 Financial outlook
13.2.3 Product summary
13.2.4 Recent developments
13.3 BioIVT & Elevating Science
13.3.1 Company details
13.3.2 Financial outlook
13.3.3 Product summary
13.3.4 Recent developments
13.4 Boca Biolistics
13.4.1 Company details
13.4.2 Financial outlook
13.4.3 Product summary
13.4.4 Recent developments
13.5 CTI Biotech
13.5.1 Company details
13.5.2 Financial outlook
13.5.3 Product summary
13.5.4 Recent developments
13.6 Cureline, Inc
13.6.1 Company details
13.6.2 Financial outlook
13.6.3 Product summary
13.6.4 Recent developments
13.7 Firalis S.A.
13.7.1 Company details
13.7.2 Financial outlook
13.7.3 Product summary
13.7.4 Recent developments
13.8 Geneticist Inc
13.8.1 Company details
13.8.2 Financial outlook
13.8.3 Product summary
13.8.4 Recent developments
13.9 ProteoGenex, Inc
13.9.1 Company details
13.9.2 Financial outlook
13.9.3 Product summary
13.9.4 Recent developments
13.10 US Biolab Corporation, Inc
13.10.1 Company details
13.10.2 Financial outlook
13.10.3 Product summary
13.10.4 Recent developments
14.List of Abbreviations
15.Reference Links
16.Conclusion
17.Research Scope

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings